Moderna stock has a neutral daily bias with a bearish short-term tilt. Price sits below its 20-session exponential average but above its longer daily averages. The hourly chart reinforces the weaker side of that picture, while the 15-minute signals offer only limited bullish counterweight.
Key takeaways
- MRNA was trading at $196.9 as of 11:45 ET on Monday, down 1.6% from the previous close.
- Daily RSI14 is 49.11, just below the neutral 50 level; the daily MACD histogram is -4.96.
- Price sits below the daily 20-session EMA at $206.94 but above the 50-session EMA at $174.07 and the 200-session EMA at $100.56.
- Hourly RSI14 is 37.04, below 50; price is below all three hourly EMAs, including the 200-hour EMA at $197.24.
- Daily ATR14 is $21.32; price is above the daily pivot at $196.69 but below the hourly pivot at $197.31.
On Monday, October 26, 2026, Moderna opened at $187.29 and traded between a low of $181.75 and a high of $203.78, and was last at $196.90, against a previous close of $200.10. It was trading at $196.9 as of 11:45 ET, down 1.6% versus the previous close. The session remains open, so the daily indicators include the forming candle.
Moderna stock faces a divided daily chart
The daily 20-session EMA stands at $206.94, above price. However, the 50-session EMA at $174.07 and the 200-session EMA at $100.56 remain below it. That leaves the daily chart without a fully bullish or bearish price-and-average alignment. The longer averages support the neutral assessment, but the nearer average remains an overhead obstacle.
Meanwhile, daily RSI14 stands at 49.11, just below 50 and outside either extreme. The MACD line is positive at 12.69 but below its signal at 17.65. Its negative histogram of -4.96 gives the daily momentum picture a bearish tilt despite the positive MACD line.
The daily Bollinger mid-band at $210.47 is also above price, with the lower band at $174.91 and upper band at $246.03. Price therefore occupies the lower half of the daily envelope. Daily ATR14 reads $21.32, providing a volatility reference rather than a directional signal.
Hourly weakness complicates the daily balance
On the hourly chart, price sits below the 200-hour EMA at $197.24, the 20-hour EMA at $208.43, and the 50-hour EMA at $216.23. Those averages are not fully bearishly ordered, but all three stand above price. Hourly RSI14 is 37.04, below 50 but not oversold. The MACD line at -8.47 is below its signal at -7.86, with a negative histogram of -0.61.
In addition, price is below the hourly Bollinger mid-band at $210.92 and above its lower band at $169.56. Hourly ATR14 is $9.31. Together, these readings reinforce the bearish side of the daily picture without establishing a fully bearish daily trend.
15-minute chart offers limited bullish offset
By contrast, the 15-minute MACD offers a narrow positive offset: its line at -1.6 is above the signal at -1.71. The 15-minute MACD histogram is positive at 0.11, although both lines remain below zero. RSI14 is 45.09, below 50. Price and the quarter-hour EMAs are bearishly aligned beneath $198.97, $204.4, and $217.29, respectively.
For short-term timing, price sits below the 15-minute Bollinger mid-band at $199.16 and above its lower band at $192.7. The 15-minute ATR14 reads $4.54. The positive histogram therefore conflicts with the bearish average alignment rather than overturning it.
Trial commentary adds context for Moderna stock
A report published by Seeking Alpha on Saturday, October 24, said Moderna’s melanoma trial with Keytruda cut recurrence risk by 42%. The report argued that a rich valuation tempered upside despite the positive Phase 3 results.
Bullish and bearish conditions for Moderna stock
The pivot levels in force come from the previous completed candle on each timeframe. Price is above the daily pivot at $196.69 but below the hourly pivot at $197.31. It is also below the 15-minute first support at $197.17 and pivot at $198.44, underscoring the short-term weakness.
For the bullish case, holding the daily pivot at $196.69 would preserve the nearest daily reference beneath price. Reclaiming the hourly 200-hour EMA at $197.24 and hourly pivot at $197.31 would strengthen that case. Further confirmation would require clearing hourly first resistance at $202.18, then the daily 20-session EMA at $206.94. Daily first resistance at $210.38 and the Bollinger mid-band at $210.47 form the next overhead references.
Conversely, a break below the daily pivot at $196.69 would undermine that bullish case. Hourly first support at $193.55 then becomes the next downside reference, followed by the 15-minute lower Bollinger band at $192.7. Below those levels, daily first support stands at $186.41. The daily lower Bollinger band at $174.91 and 50-session EMA at $174.07 define a deeper support area.
Overall, Moderna stock stands just above its daily pivot but below nearby hourly reference levels and its daily 20-session EMA. Daily ATR14 of $21.32 keeps volatility central to the assessment. The unresolved question is whether price can reclaim overhead levels while the daily momentum readings remain mixed.
FAQ
What is the daily technical picture for Moderna stock?
The daily chart is divided. Price sits below the 20-session EMA at $206.94 but above the 50-session EMA at $174.07 and the 200-session EMA at $100.56. Daily RSI14 is 49.11, just below 50. The MACD line is positive at 12.69 but below its signal at 17.65, with a negative histogram of -4.96. The daily Bollinger mid-band at $210.47 is also above price.
What do the hourly and 15-minute charts show for MRNA?
The hourly chart shows price below all three EMAs — the 200-hour at $197.24, the 20-hour at $208.43, and the 50-hour at $216.23. Hourly RSI14 is 37.04, below 50. The MACD line at -8.47 is below its signal at -7.86. On the 15-minute chart, the MACD offers a narrow positive offset with a histogram of 0.11, but both MACD lines remain below zero and price sits below all three quarter-hour EMAs.
What are the key levels to watch for Moderna stock?
Price is above the daily pivot at $196.69 but below the hourly pivot at $197.31. On the upside, hourly first resistance is at $202.18, followed by the daily 20-session EMA at $206.94 and daily first resistance at $210.38. On the downside, hourly first support stands at $193.55, with daily first support at $186.41. The daily lower Bollinger band at $174.91 and 50-session EMA at $174.07 form a deeper support area.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument. The analysis provided is not indicative of future results. Investing in financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Cryptonomist and the author hold no positions in the financial instruments mentioned and receive no compensation from the companies covered.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.